Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.
Bes F, Hofman W, Schuur J, Van Boxtel C · 1992 · Neuropsychobiology 26(4):193-197
What does this source report?
Some objective measures favored DSIP, but effects were weak and partly attributable to placebo-group changes. Subjective sleep quality did not improve; authors judged substantial short-term benefit unlikely.
- Population and setting
- 16 patients; double-blind matched-pairs parallel groups
- Evidence type
- Clinical trial / comparison
- Preparation
- Ordinary DSIP
- Source language
- eng
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Small, brief study; selected statistically significant endpoints do not establish a meaningful overall benefit.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.
Recorded source-check date: 2026-10-01. This date does not imply a completed systematic review.
Open original source or index record ↗
DOI: 10.1159/000118919
Cite and trace this record
Original source: Bes F, Hofman W, Schuur J, Van Boxtel C. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study. Neuropsychobiology 26(4):193-197 1992.
Molekul research summary: https://molekul.io/research/dsip-1299794. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry